We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TV:NYSEGrupo Televisa S.A.B. Analysis

Data as of 2026-09-16 - not real-time

$2.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Grupo Televisa, S.A.B. trades at $2.19, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 20.4% over the past 30 days. RSI sits at 21.7, which reads as oversold, and MACD momentum is bearish. Watch $2.18 as support and $2.90 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 15.0 sits in line with the sector average of 15.6. Consensus targets land 82.3% above where the shares trade now. Revenue is contracting at 3.0% on a -16.3% profit margin. The 3.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 40.7%, a beta of 0.75 and a maximum drawdown of 36.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Seeking Alpha1monGrupo Televisa's Q2 Earnings: What May Matter Most Is Not In The ReportGrupo Televisa remains a...Detailed price information for Grupo Televisa S.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 21.7 signals oversold conditions
  • Trading below the 200-day average of 2.89

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 21.7 signals oversold conditions
  • P/E of 15.0 versus sector average of 15.6

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 15.0 versus sector average of 15.6
  • Negative profit margin of -16.3%
  • Analyst targets imply +82.3% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-3.00%
Profit Margin-16.26%
P/E Ratio15.0
ROE-7.96%
ROA1.73%
Debt/Equity78.64
P/B Ratio0.2
Op. Cash Flow$23.0B
Free Cash Flow$5.3B
Industry P/E15.6

Technical Analysis

TrendBearish
RSI21.7
Support$2.18
Resistance$2.90
MA 20$2.60
MA 50$2.71
MA 200$2.89
MACDBearish
VolumeIncreasing
Fear & Greed Index89.8

Valuation

Fair Value$37.18
Target Price$3.99
Upside/Downside82.32%
GradeUndervalued
TypeValue
Dividend Yield3.41%

Risk Assessment

Beta0.75
Volatility40.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.